tiprankstipranks
Aardvark Therapeutics, Inc. (AARD)
NASDAQ:AARD
US Market
AARD
Aardvark Therapeutics, Inc.
RESEARCH TOOLSreports

Aardvark Therapeutics, Inc. (AARD) Financial Statements

151 Followers

Aardvark Therapeutics, Inc. Financial Overview

Aardvark Therapeutics, Inc.'s market cap is currently $93.81M. The company's EPS TTM is $; its P/E ratio is -4.47; Aardvark Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -36.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -62.73M$ -22.79M$ -7.42M$ -11.36M
EBITDA$ -62.73M$ -22.65M$ -6.65M$ -9.76M
Net Income$ -57.59M$ -20.59M$ -7.21M$ -13.56M
Balance Sheet
Cash & Short-Term Investments$ 110.03M$ 73.66M$ 9.99M$ 16.11M
Total Assets$ 117.18M$ 77.51M$ 10.54M$ 16.76M
Total Debt$ 441.00K$ 779.00K$ 162.00K$ 262.00K
Net Debt$ -46.61M$ -60.86M$ -9.57M$ -15.30M
Total Liabilities$ 10.55M$ 132.15M$ 45.34M$ 44.68M
Stockholders' Equity$ 106.63M$ -54.64M$ -34.80M$ -27.92M
Cash Flow
Free Cash Flow$ -54.27M$ -18.20M$ -5.82M$ -10.54M
Operating Cash Flow$ -54.17M$ -18.09M$ -5.82M$ -10.54M
Investing Cash Flow$ -49.67M$ -12.00M$ 0.00$ -1.00M
Financing Cash Flow$ 89.25M$ 81.99M$ 0.00$ 225.00K
Currency in USD

Aardvark Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Aardvark Therapeutics, Inc. Debt to Assets

Balance Sheet >

Aardvark Therapeutics, Inc. Cash Flow

Cash Flow >

Aardvark Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >